Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Ayala, R.
- Carreño-Tarragona, G.
- Barragán, E.
- Boluda, B.
- Larráyoz, M. J.
- Chillón, M. Carmen
- Carrillo-Cruz, E.
- Bilbao, C.
- Sánchez-GarcÃa, J.
- Bernal, T.
- Martinez-Cuadron, D.
- Gil, C.
- Serrano, J.
- Rodriguez-Medina, C.
- Bergua, J.
- Pérez-Simón, J. A.
- Calbacho, M.
- Alonso-DomÃnguez, J. M.
- Labrador, J.
- Tormo, M.
- Amigo, M. Luz
- Herrera-Puente, P.
- Rapado, I.
- Sargas, C.
- Vazquez, I.
- Calasanz, M. J.
- Gomez-Casares, T.
- GarcÃa-Sanz, R.
- Sanz, M. A.
- MartÃnez-López, J.
- Montesinos, P.
- on Google Scholar
- Ayala, R.
- Carreño-Tarragona, G.
- Barragán, E.
- Boluda, B.
- Larráyoz, M. J.
- Chillón, M. Carmen
- Carrillo-Cruz, E.
- Bilbao, C.
- Sánchez-GarcÃa, J.
- Bernal, T.
- Martinez-Cuadron, D.
- Gil, C.
- Serrano, J.
- Rodriguez-Medina, C.
- Bergua, J.
- Pérez-Simón, J. A.
- Calbacho, M.
- Alonso-DomÃnguez, J. M.
- Labrador, J.
- Tormo, M.
- Amigo, M. Luz
- Herrera-Puente, P.
- Rapado, I.
- Sargas, C.
- Vazquez, I.
- Calasanz, M. J.
- Gomez-Casares, T.
- GarcÃa-Sanz, R.
- Sanz, M. A.
- MartÃnez-López, J.
- Montesinos, P.
- on PubMed
- Ayala, R.
- Carreño-Tarragona, G.
- Barragán, E.
- Boluda, B.
- Larráyoz, M. J.
- Chillón, M. Carmen
- Carrillo-Cruz, E.
- Bilbao, C.
- Sánchez-GarcÃa, J.
- Bernal, T.
- Martinez-Cuadron, D.
- Gil, C.
- Serrano, J.
- Rodriguez-Medina, C.
- Bergua, J.
- Pérez-Simón, J. A.
- Calbacho, M.
- Alonso-DomÃnguez, J. M.
- Labrador, J.
- Tormo, M.
- Amigo, M. Luz
- Herrera-Puente, P.
- Rapado, I.
- Sargas, C.
- Vazquez, I.
- Calasanz, M. J.
- Gomez-Casares, T.
- GarcÃa-Sanz, R.
- Sanz, M. A.
- MartÃnez-López, J.
- Montesinos, P.
Need Help?
Order Article Reprints
Journal: Cancers, 2022
Volume: 14
Number: 5799
5799
Article:
Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
Authors:
by
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, MarÃa J. Larráyoz, MarÃa Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao, JoaquÃn Sánchez-GarcÃa, Teresa Bernal, David Martinez-Cuadron, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José A. Pérez-Simón, MarÃa Calbacho, Juan M. Alonso-DomÃnguez, Jorge Labrador, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, MarÃa J. Calasanz, Teresa Gomez-Casares, Ramón GarcÃa-Sanz, Miguel A. Sanz, JoaquÃn MartÃnez-López and Pau Montesinosadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/14/23/5799
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Ayala, R.; Carreño-Tarragona, G.; Barragán, E.; Boluda, B.; Larráyoz, M.J.; Chillón, M.C.; Carrillo-Cruz, E.; Bilbao, C.; Sánchez-GarcÃa, J.; Bernal, T.; et al. Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 2022, 14, 5799. https://doi.org/10.3390/cancers14235799
Ayala R, Carreño-Tarragona G, Barragán E, Boluda B, Larráyoz MJ, Chillón MC, Carrillo-Cruz E, Bilbao C, Sánchez-GarcÃa J, Bernal T, et al. Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers. 2022; 14(23):5799. https://doi.org/10.3390/cancers14235799
Chicago/Turabian StyleAyala, Rosa, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, MarÃa J. Larráyoz, MarÃa Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao, JoaquÃn Sánchez-GarcÃa, Teresa Bernal, and et al. 2022. "Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study" Cancers 14, no. 23: 5799. https://doi.org/10.3390/cancers14235799
APA StyleAyala, R., Carreño-Tarragona, G., Barragán, E., Boluda, B., Larráyoz, M. J., Chillón, M. C., Carrillo-Cruz, E., Bilbao, C., Sánchez-GarcÃa, J., Bernal, T., Martinez-Cuadron, D., Gil, C., Serrano, J., Rodriguez-Medina, C., Bergua, J., Pérez-Simón, J. A., Calbacho, M., Alonso-DomÃnguez, J. M., Labrador, J., ... Montesinos, P. (2022). Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers, 14(23), 5799. https://doi.org/10.3390/cancers14235799
